Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong
· Delayed Price · Currency is HKD 0.800
+0.040 (5.26%)
At close: Mar 10, 2026
HKG:3737 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 691 | 855 | 1,226 | 941 | 855 | 1,403 | Upgrade
|
| Market Cap Growth | -15.79% | -30.28% | 30.28% | 10.10% | -39.05% | 29.46% | Upgrade
|
| Enterprise Value | 656 | 860 | 1,109 | 806 | 770 | 1,154 | Upgrade
|
| Last Close Price | 0.80 | 0.94 | 1.30 | 0.88 | 0.80 | 1.35 | Upgrade
|
| PE Ratio | 35.01 | 8.44 | 6.84 | 7.83 | 13.36 | 8.53 | Upgrade
|
| Forward PE | - | 10.30 | 10.30 | 10.30 | 10.30 | 10.30 | Upgrade
|
| PS Ratio | 0.31 | 0.36 | 0.54 | 0.46 | 0.40 | 0.74 | Upgrade
|
| PB Ratio | 0.58 | 0.72 | 1.06 | 0.83 | 0.77 | 1.44 | Upgrade
|
| P/TBV Ratio | 0.59 | 0.73 | 1.08 | 0.85 | 0.79 | 1.48 | Upgrade
|
| P/FCF Ratio | 4.72 | 19.73 | - | 4.25 | - | - | Upgrade
|
| P/OCF Ratio | 3.19 | 4.43 | 10.97 | 2.93 | 3.91 | 12.68 | Upgrade
|
| PEG Ratio | - | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | Upgrade
|
| EV/Sales Ratio | 0.30 | 0.37 | 0.49 | 0.39 | 0.36 | 0.61 | Upgrade
|
| EV/EBITDA Ratio | 4.69 | 4.69 | 4.67 | 4.63 | 5.24 | 4.77 | Upgrade
|
| EV/EBIT Ratio | 25.88 | 6.46 | 6.12 | 6.89 | 7.88 | 6.88 | Upgrade
|
| EV/FCF Ratio | 4.48 | 19.84 | - | 3.63 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.17 | 0.17 | 0.17 | 0.20 | 0.23 | Upgrade
|
| Debt / EBITDA Ratio | 1.09 | 0.81 | 0.66 | 0.87 | 1.08 | 0.78 | Upgrade
|
| Debt / FCF Ratio | 1.04 | 4.63 | - | 0.87 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.03 | -0.01 | -0.02 | -0.25 | -0.09 | -0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.51 | -0.06 | -0.08 | -1.61 | -0.69 | -0.60 | Upgrade
|
| Net Debt / FCF Ratio | -0.28 | -0.27 | 0.26 | -1.27 | 10.99 | 5.92 | Upgrade
|
| Asset Turnover | 1.06 | 1.17 | 1.12 | 1.07 | 1.19 | 1.19 | Upgrade
|
| Inventory Turnover | 2.69 | 2.76 | 2.56 | 2.57 | 2.66 | 2.75 | Upgrade
|
| Quick Ratio | 0.94 | 0.89 | 0.87 | 1.01 | 1.13 | 1.23 | Upgrade
|
| Current Ratio | 1.54 | 1.39 | 1.44 | 1.49 | 1.71 | 1.82 | Upgrade
|
| Return on Equity (ROE) | 1.88% | 8.84% | 15.94% | 11.21% | 6.08% | 17.49% | Upgrade
|
| Return on Assets (ROA) | 0.76% | 4.14% | 5.60% | 3.81% | 3.38% | 6.53% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.07% | 7.63% | 14.50% | 10.75% | 8.88% | 19.48% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.90% | 10.00% | 13.90% | 9.00% | 7.80% | 15.10% | Upgrade
|
| Earnings Yield | 3.26% | 11.85% | 14.62% | 12.78% | 7.48% | 11.73% | Upgrade
|
| FCF Yield | 21.19% | 5.07% | -6.08% | 23.56% | -1.07% | -1.76% | Upgrade
|
| Dividend Yield | 6.58% | 5.35% | 6.90% | 6.80% | - | 2.74% | Upgrade
|
| Payout Ratio | 187.55% | 24.30% | 71.35% | - | - | 35.35% | Upgrade
|
| Buyback Yield / Dilution | 0.36% | 0.18% | - | -1.20% | -0.98% | 0.69% | Upgrade
|
| Total Shareholder Return | 6.94% | 5.53% | 6.90% | 5.60% | -0.98% | 3.43% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.